Taumedika s.r.l.
Study to validate the safety and efficacy of the Hyaluronic Acid +Collagen filler 20 patients will undergo through 3 visits one to asses the health and apply the filler one after 4 weeks to check the results one after 16 weeks for the final check and results validation Safety assessed with analysis of the Adverse Events
Wrinkle
Scar
Laxity; Skin
Karisma
NA
The patients chosen with facial laxity characteristics, at the first visit will be assessed and will receive the treatment (microinjections) in the cheekbone area, over the lips and in the marionette lines. After 4 weeks the first visit will assess the change of the tissutal structure with non invasive measurements.
| Study Type : | INTERVENTIONAL |
| Estimated Enrollment : | 20 participants |
| Masking : | NONE |
| Primary Purpose : | TREATMENT |
| Official Title : | Pre-marketing Clinical Trial to Evaluate the Safety and Efficacy of the Voluming Filler Based on Hyaluronic Acid Recombinant Collagen |
| Actual Study Start Date : | 2024-12 |
| Estimated Primary Completion Date : | 2025-03 |
| Estimated Study Completion Date : | 2025-06 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years to 70 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
No Location Found